Retatrutide 15 mg × 5 Vials
Batch-tested · Switzerland
Peptide · Vial kit

Retatrutide 15 mg × 5 vials.

Retatrutide (LY3437943) is a synthetic acylated peptide that acts on three receptors at once: GLP-1, GIP and glucagon.

Strength
15 mg / vial
Pack
5 vials
Format
Freeze-dried
Research area
Metabolic

Have this box? Check it's genuine.

Type the six digits from the label.

Have this box? Check it's genuine.

For laboratory research use only. Not for human consumption.

Reference profile
Reference profile

What it is.

Retatrutide (LY3437943) is a synthetic acylated peptide that acts on three receptors at once: GLP-1, GIP and glucagon. It belongs to the newest class of incretin-based research compounds.

Key facts
  • Triple agonist
  • GLP-1 · GIP · Glucagon
  • LY3437943

How it is used.

Retatrutide is studied in models of obesity, type 2 diabetes and metabolic syndrome. Research tracks body weight, blood glucose, insulin sensitivity and liver fat, often alongside single- and dual-agonist compounds for comparison.

Studied in
  • Obesity models
  • Type 2 diabetes models
  • Liver fat studies
Quality

Tested before it's boxed.

Every batch is made in-house in Switzerland and tested for identity, purity and sterility before it is packed.

How we test
Every batch is tested for
  • Identity LC-MS
  • Content HPLC-UV
  • Purity HPLC-UV
  • Sterility USP <71>
  • Endotoxins USP <85>
  • Particulates USP <788>